American journal of human genetics · 2009
Genetic control of human brain transcript expression in Alzheimer disease.
СтатьяПоддержка NIH: внешняя программаНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Webster Jennifer A, Gibbs J Raphael, Clarke Jennifer, Ray Monika, Zhang Weixiong, Holmans Peter, Rohrer Kristen, Zhao Alice, Marlowe Lauren, Kaleem Mona, McCorquodale Donald S, Cuello Cindy, Leung Doris, Bryden Leslie, Nath Priti, Zismann Victoria L, Joshipura Keta, Huentelman Matthew J, Hu-Lince Diane, Coon Keith D, Craig David W, Pearson John V, NACC-Neuropathology Group, Heward Christopher B, Reiman Eric M, Stephan Dietrich, Hardy John, Myers Amanda J
Аннотация
We recently surveyed the relationship between the human brain transcriptome and genome in a series of neuropathologically normal postmortem samples. We have now analyzed additional samples with a confirmed pathologic diagnosis of late-onset Alzheimer disease (LOAD; final n = 188 controls, 176 cases). Nine percent of the cortical transcripts that we analyzed had expression profiles correlated with their genotypes in the combined cohort, and approximately 5% of transcripts had SNP-transcript relationships that could distinguish LOAD samples. Two of these transcripts have been previously implicated in LOAD candidate-gene SNP-expression screens. This study shows how the relationship between common inherited genetic variants and brain transcript expression can be used in the study of human brain disorders. We suggest that studying the transcriptome as a quantitative endo-phenotype has greater power for discovering risk SNPs influencing expression than the use of discrete diagnostic categories such as presence or absence of disease.